DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
Ettinger B, Black DM, Mitlak BH. et al.
Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomised clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) investigators.
JAMA 1999; 282: 637-645
We do not assume any responsibility for the contents of the web pages of other providers.